183208-35-7
Product Name:
5-Bromo-7-azaindole
Formula:
C7H5BrN2
Synonyms:
5-Bromo-1H-pyrrolo[2,3-b]pyridine
Inquiry
SAFETY INFORMATION
| Signal word | Danger |
|---|---|
| Pictogram(s) |
 Corrosion Corrosives GHS05  Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H318:Serious eye damage/eye irritation |
| Precautionary Statement Codes |
P280:Wear protective gloves/protective clothing/eye protection/face protection. |
COMPUTED DESCRIPTORS
| Molecular Weight | 197.03 g/mol |
|---|---|
| XLogP3 | 2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 195.96361 g/mol |
| Monoisotopic Mass | 195.96361 g/mol |
| Topological Polar Surface Area | 28.7 Ų |
| Heavy Atom Count | 10 |
| Formal Charge | 0 |
| Complexity | 129 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently-Bonded Unit Count | 1 |
| Compound Is Canonicalized | Yes |
PRODUCT INTRODUCTION
Description
5-Bromo-7-azaindole is used as an intermediate in Venetoclax, a targeted cancer drug for the treatment of chronic lymphocytic carcinoma (CLL) or small lymphocytic lymphoma (SLL).